Table 1. Association analysis of genetic variants in DNA repair genes with the risk of NHL.

					Stage 1		Stage 2		Stage 1 & 2 [Aggregate]
					(650 Cases/965 Controls)		(647 Cases/981 Controls)		(1,297 Cases/1,946 Controls)
Gene	Chr.	SNP	Minor Allele	Allele Freq.	OR (95% CI)	P	OR (95% CI)	P	OR (95% CI)	P
ATM	11	rs227060	T	0.37	1.27 (1.07–1.49)	0.0057	1.30 (1.10–1.54)	0.0020	1.27 (1.13–1.43)	6.77×10−5
ATM	11	rs611646	T	0.45	1.24 (1.04–1.49)	0.016	1.30 (1.10–1.54)	0.0020	1.26 (1.12–1.43)	1.52×10−4
GTF2H1	11	rs4150606	A	0.50	0.82 (0.69–0.97)	0.021	0.81 (0.68–0.95)	0.013	0.81 (0.72–0.92)	6.68×10−4
MSH2	2	rs4952887	T	0.07	0.66 (0.47–0.91)	0.012	0.76 (0.58–1.01)	0.055	0.71 (0.57–0.87)	0.00128
MRE11A	11	rs625245	C	0.32	0.78 (0.65–0.93)	0.0066	0.84 (0.69–1.01)	0.059	0.81 (0.71–0.93)	0.0018
ATM	11	rs419716	T	0.42	0.8 (0.67–0.96)	0.014	0.85 (0.71–1.01)	0.056	0.83 (0.73–0.94)	0.0025
POLQ	3	rs702019	G	0.23	0.77 (0.62–0.95)	0.013	0.90 (0.74–1.09)	0.271	0.84 (0.73–0.96)	0.013
TDP1	14	rs7149962	C	0.06	1.49 (1.07–2.08)	0.020	1.19 (0.85–1.65)	0.307	1.33 (1.05–1.68)	0.019
NBS1	8	rs1805812	C	0.06	0.87 (0.59–1.27)	0.466	0.65 (0.46–0.94)	0.021	0.75 (0.58–0.97)	0.028
CCNH	5	rs3093819	T	0.46	1.14 (0.96–1.34)	0.128	1.13 (0.96–1.34)	0.139	1.14 (1.01–1.28)	0.030
MRE11A	11	rs10831227	A	0.34	0.93 (0.79–1.1)	0.382	0.83 (0.70–0.99)	0.035	0.88 (0.78–0.99)	0.030
CHEK1	11	rs565416	A	0.32	0.79 (0.66–0.94)	0.0075	0.99 (0.84–1.17)	0.892	0.88 (0.78–0.99)	0.037
MSH6	2	rs7562048	G	0.44	0.79 (0.66–0.93)	0.0062	0.98 (0.82–1.16)	0.818	0.88 (0.78–0.99)	0.039
NBS1	8	rs14448	C	0.06	0.99 (0.70–1.40)	0.936	1.61 (1.16–2.23)	0.0043	1.28 (1.01–1.62)	0.041
ATR	3	rs10804682	A	0.20	1.24 (1.02–1.51)	0.031	1.09 (0.90–1.32)	0.375	1.15 (1.01–1.32)	0.042

OR = odds ratio; CI = confidence interval.